Trade Mark Journal No.2026/012 20 March 2026

UK00004315564 24 December 2025 (5,35,36,41,42,44)

GENETIX BIOTHERAPEUTICS

International priority date claimed: 18 September 2025 (United States of America) (99399475)
Class 5
Pharmaceutical preparations and substances for the treatment of genetic diseases; Pharmaceutical preparations for the treatment of blood diseases; Pharmaceutical preparations and substances.
Class 35
Providing a service for connecting medical patients and physicians with qualified treatment centres for gene therapy via a website.
Class 36
Providing a web site featuring educational information relating to insurance and financing for gene therapy.
Class 41
Providing educational information relating to insurance and financing for gene therapy; Providing educational information via the internet relating to insurance and financing for gene therapy;   Providing educational information relating to genetic diseases and treatment for genetic diseases;   Providing a website that features educational information relating to genetic diseases and treatment for genetic diseases; Providing educational information via the internet relating to genetic diseases and treatment for genetic diseases; Arranging and conducting of conferences, seminars, symposiums, classes, workshops, presentations, seminars, and in-person educational forums in the field of gene therapy; Providing prerecorded audio, visual, and audio-visual educational programs, not downloadable, via video-on-demand services, that relate to gene therapy.
Class 42
Pharmaceutical research and development; Research and development in the field of genetic diseases and gene therapies; Providing online non-downloadable software for documenting data on the source, manufacturer, packaging, storage, transport, and delivery of materials for use in therapies and therapeutics.
Class 44
Providing medical information in the field of genetic diseases and gene therapies via a website; Providing a website featuring medical information in the field of genetic diseases and gene therapies; Medical information services provided via the internet; .

Genetix Biotherapeutics Inc.

Representative: Keltie LLP